HMTXF
Price:
$0.0466
Market Cap:
$11.87M
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.
Industry
Biotechnology
IPO Date
2016-01-07
Stock Exchange
OTC
Ticker
HMTXF
According to Hemostemix Inc’s latest financial reports and current stock price. The company's current PE Ratio is -1.92. This represents a change of -72.47% compared to the average of -6.97 of the last 4 quarters.
The mean historical PE Ratio of Hemostemix Inc over the last ten years is -2.72. The current -1.92 PE Ratio has changed 6.97% with respect to the historical average. Over the past ten years (40 quarters), HMTXF's PE Ratio was at its highest in in the September 2020 quarter at -0.58. The PE Ratio was at its lowest in in the June 2025 quarter at -15.48.
Average
-2.72
Median
-2.71
Minimum
-4.36
Maximum
-0.63
Discovering the peaks and valleys of Hemostemix Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 366.67%
Maximum Annual PE Ratio = -0.63
Minimum Annual Increase = -83.98%
Minimum Annual PE Ratio = -4.36
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.13 | -28.39% |
| 2024 | -4.36 | 88.88% |
| 2023 | -2.31 | -4.00% |
| 2022 | -2.41 | 65.44% |
| 2021 | -1.45 | -50.13% |
| 2020 | -2.92 | 366.67% |
| 2019 | -0.63 | -83.98% |
| 2018 | -3.90 | 56.10% |
| 2017 | -2.50 | -30.00% |
| 2016 | -3.57 | -63.31% |
The current PE Ratio of Hemostemix Inc (HMTXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.27
5-year avg
-2.73
10-year avg
-2.72
Hemostemix Inc’s PE Ratio is less than Nymox Pharmaceutical Corporation (-0.21), greater than Devonian Health Group Inc. (-4.50), less than HOOKIPA Pharma Inc. (-0.71), less than Algorae Pharmaceuticals Limited (24.00), greater than EOM Pharmaceuticals Holdings, Inc. (-8.55), less than Sirona Biochem Corp. (-0.71), less than Oxford BioDynamics Plc (-0.31), greater than Inhibitor Therapeutics, Inc. (-4.12), less than Quest PharmaTech Inc. (0.98), greater than Cell Source, Inc. (-8.23),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.21 | $954.86K | |
| -4.50 | $19.47M | |
| -0.71 | $14.40M | |
| 24.00 | $19.36M | |
| -8.55 | $16.45M | |
| -0.71 | $1.63M | |
| -0.31 | $5.33M | |
| -4.12 | $13.81M | |
| 0.98 | $3.38M | |
| -8.23 | $37.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemostemix Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemostemix Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hemostemix Inc's PE Ratio?
How is the PE Ratio calculated for Hemostemix Inc (HMTXF)?
What is the highest PE Ratio for Hemostemix Inc (HMTXF)?
What is the 3-year average PE Ratio for Hemostemix Inc (HMTXF)?
What is the 5-year average PE Ratio for Hemostemix Inc (HMTXF)?
How does the current PE Ratio for Hemostemix Inc (HMTXF) compare to its historical average?